Mr. Speaker, I have heard my colleague bring this issue up in the House today. I appreciate that he is advocating so fiercely for some of his constituents, which is wonderful to see.
As other members in the House have mentioned, bringing in a universal pharmacare program does not mean we are giving up on continuing to advance the need for specific medications for people with rare diseases. We can lift everybody up and work toward equal access, which we have do together. However, this is not about throwing one system out and replacing it with another.